Germline Pathogenic Variants AmongWomenWithout a History of Breast Cancer A Secondary Analysis of the WISDOM Randomized Clinical Trial Por Adson Machado Germline Pathogenic Variants AmongWomenWithout a History of Breast Cancer A Secondary Analysis of the WISDOM Randomized Clinical Trial Read More »
Pooled analysis by best confirmed response to trastuzumab deruxtecan andrelated biomarkers in patients with HER2-positive metastatic breast cancerfrom DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03 Por Adson Machado Pooled analysis by best confirmed response to trastuzumab deruxtecan andrelated biomarkers in patients with HER2-positive metastatic breast cancerfrom DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03 Read More »
Impact of neoadjuvant immunotherapy on postoperative complications inoncoplastic breast cancer surgery Por Adson Machado Impact of neoadjuvant immunotherapy on postoperative complications inoncoplastic breast cancer surgery Read More »
The impact of multicancer early detection tests on cancer stage shift: A10 – year micro simulation model Por Adson Machado The impact of multicancer early detection tests on cancer stage shift: A10 – year micro simulation model Read More »
Treatment of infertility and risk of breast cancer among women with a BRCA pathogenic variant: a matched case-control study Por Adson Machado Treatment of infertility and risk of breast cancer among women with a BRCA pathogenic variant: a matched case-control study Read More »
The impact of immediate lipofilling on oncological outcomes, complicationrates and patient reported outcomes in breast conserving surgery: asystematic review and meta-analysis Por Adson Machado The impact of immediate lipofilling on oncological outcomes, complicationrates and patient reported outcomes in breast conserving surgery: asystematic review and meta-analysis Read More »
Patritumab deruxtecan (HER3-DXd) in patients with activebrain metastases of breast cancer (TUXEDO-3):a multicentre, single-arm, phase 2 trial Por Adson Machado Patritumab deruxtecan (HER3-DXd) in patients with activebrain metastases of breast cancer (TUXEDO-3):a multicentre, single-arm, phase 2 trial Read More »
The recurrence and mortality risk in Luminal a breast cancer patients who lived in high pollution area Por Adson Machado The recurrence and mortality risk in Luminal a breast cancer patients who lived in high pollution area Read More »
Hormonal Contraceptive Formulations and Breast Cancer Riskin Adolescents and Premenopausal Women Por Adson Machado Hormonal Contraceptive Formulations and Breast Cancer Riskin Adolescents and Premenopausal Women Read More »
Ninety Days of Preoperative Endocrine Therapy Informs Patientand Physician Preference for Radiation Therapy: Primary Resultsfrom the Preoperative Window of Endocrine Therapy to InformRadiation Therapy Decisions (POWER) Trial Por Kati Ninety Days of Preoperative Endocrine Therapy Informs Patientand Physician Preference for Radiation Therapy: Primary Resultsfrom the Preoperative Window of Endocrine Therapy to InformRadiation Therapy Decisions (POWER) Trial Read More »
Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSOClinical Practice Guideline Por Kati Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSOClinical Practice Guideline Read More »
Real-world progression-free survival of CDK4/6 inhibitors plus anaromatase inhibitor in HR-positive/HER2-negative metastatic breast cancerin United States routine clinical practice Por Adson Machado Real-world progression-free survival of CDK4/6 inhibitors plus anaromatase inhibitor in HR-positive/HER2-negative metastatic breast cancerin United States routine clinical practice Read More »
